PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis
- DOI
- 10.1038/s41419-022-04576-4
- Published
- 2022-02-04
- Container
- Cell Death & Disease
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-022-04576-4,
title = {PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis},
author = {Yu He and Xixi Wang and Weiliang Lu and Dan Zhang and Lan Huang and Yang Luo and Li Xiong and Haocheng Li and Peng Zhang and Qiu Li and Shufang Liang},
year = {2022},
journal = {Cell Death \& Disease},
doi = {10.1038/s41419-022-04576-4},
url = {https://doi.org/10.1038/s41419-022-04576-4}
}RIS
TY - JOUR TI - PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis AU - Yu He AU - Xixi Wang AU - Weiliang Lu AU - Dan Zhang AU - Lan Huang AU - Yang Luo AU - Li Xiong AU - Haocheng Li AU - Peng Zhang AU - Qiu Li AU - Shufang Liang PY - 2022 JO - Cell Death & Disease DO - 10.1038/s41419-022-04576-4 UR - https://doi.org/10.1038/s41419-022-04576-4 ER -
APA
He, Y., Wang, X., Lu, W., Zhang, D., Huang, L., Luo, Y., Xiong, L., Li, H., Zhang, P., Li, Q., & Liang, S. (2022). PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis. Cell Death & Disease. https://doi.org/10.1038/s41419-022-04576-4
Source records
- crossref · retrieved 2026-09-25T16:28:56.054Z